Apolipoprotein A-II Plus Lipid Emulsion Enhance Cell Growth via SR-B1 and Target Pancreatic Cancer In Vitro and In Vivo

BACKGROUND: Apolipoprotein A-II (ApoA-II) is down regulated in the sera of pancreatic ductal adenocarcinoma (PDAC) patients, which may be due to increase utilization of high density lipoprotein (HDL) lipid by pancreatic cancer tissue. This study examined the influence of exogenous ApoA-II on lipid u...

Descripción completa

Detalles Bibliográficos
Autores principales: Julovi, Sohel M., Xue, Aiqun, Thanh LE, Thao N., Gill, Anthony J., Bulanadi, Jerikho C., Patel, Mili, Waddington, Lynne J., Rye, Kerry-Anne, Moghaddam, Minoo J., Smith, Ross C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803224/
https://www.ncbi.nlm.nih.gov/pubmed/27002321
http://dx.doi.org/10.1371/journal.pone.0151475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803224/
https://www.ncbi.nlm.nih.gov/pubmed/27002321
http://dx.doi.org/10.1371/journal.pone.0151475

Ejemplares similares